Linney; Ian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Linney; Ian.The latest application filed is for "substituted isindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,3-c]pyridin-1-ones as hpk1 antagonists".

Company Profile

7.27.26

Linney; Ian - Saffron Walden GB
Linney; Ian - Parma N/A IT
Linney; Ian - Saffron Walden Essex N/A GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists Grant 11,078,201 - Kaila , et al. August 3, 2	2021-08-03
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists Grant 11,034,694 - Kaila , et al. June 15, 2	2021-06-15
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists Grant 11,028,085 - Kaila , et al. June 8, 2	2021-06-08
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists Grant 11,021,481 - Kaila , et al. June 1, 2	2021-06-01
SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS App 20210087190 - KAILA; Neelu ; et al.	2021-03-25
SUBSTITUTED ISINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,3-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS App 20210087189 - KAILA; Neelu ; et al.	2021-03-25
SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROLO[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS App 20210078998 - KAILA; Neelu ; et al.	2021-03-18
SUBSTITUTED ISOINDOLIN-1-ONES AND 2,3-DIHYDRO-1H-PYRROL[3,4-c]PYRIDIN-1-ONES AS HPK1 ANTAGONISTS App 20210078997 - KAILA; Neelu ; et al.	2021-03-18
Hpk1 Antagonists And Uses Thereof App 20210078996 - KAILA; Neelu ; et al.	2021-03-18
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 10,196,386 - Rancati , et al. Fe	2019-02-05
Aminoester derivatives Grant 10,117,860 - Armani , et al. November 6, 2	2018-11-06
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 10,004,728 - Rancati , et al. June 26, 2	2018-06-26
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,932,338 - Carzaniga , et al. April 3, 2	2018-04-03
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20180016267 - RANCATI; Fabio ; et al.	2018-01-18
Aminoester Derivatives App 20170340616 - Armani; Elisabetta ; et al.	2017-11-30
Aminoester derivatives Grant 9,763,924 - Armani , et al. September 19, 2	2017-09-19
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170158694 - CARZANIGA; Laura ; et al.	2017-06-08
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,662,323 - Carzaniga , et al. May 30, 2	2017-05-30
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170119753 - RANCATI; Fabio ; et al.	2017-05-04
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,579,314 - Rancati , et al. February 28, 2	2017-02-28
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160346271 - CARZANIGA; Laura ; et al.	2016-12-01
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,453,013 - Rancati , et al. September 27, 2	2016-09-27
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160235734 - RANCATI; Fabio ; et al.	2016-08-18
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,371,318 - Rancati , et al. June 21, 2	2016-06-21
Aminoester Derivatives App 20150352091 - ARMANI; Elisabetta ; et al.	2015-12-10
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150139916 - RANCATI; Fabio ; et al.	2015-05-21
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20150133491 - RANCATI; Fabio ; et al.	2015-05-14
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,012,644 - Rancati , et al. April 21, 2	2015-04-21
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 8,987,299 - Rancati , et al. March 24, 2	2015-03-24
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 8,980,913 - Rancati , et al. March 17, 2	2015-03-17
Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity Grant 8,877,774 - Rancati , et al. November 4, 2	2014-11-04
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions Grant 8,853,193 - Heckel , et al. October 7, 2	2014-10-07
Cycloalkyl containing thienopyrimidines for pharmaceutical compositions Grant 8,754,079 - Lehmann-Lintz , et al. June 17, 2	2014-06-17
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140161736 - Rancati; Fabio ; et al.	2014-06-12
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20140163066 - RANCATI; Fabio ; et al.	2014-06-12
Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions Grant 8,648,068 - Lehmann-Lintz , et al. February 11, 2	2014-02-11
Thienopyrimidines for pharmaceutical compositions Grant 8,486,953 - Austen , et al. July 16, 2	2013-07-16
Halogen Or Cyano Substituted Thieno [2,3-d]pyrimidines Having Mnk1/mnk2 Inhibiting Activity For Pharmaceutical Compositions App 20130065914 - Heckel; Armin ; et al.	2013-03-14
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130045169 - Rancati; Fabio ; et al.	2013-02-21
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20130034504 - RANCATI; Fabio ; et al.	2013-02-07
Thienopyrimidines For Pharmaceutical Compositions App 20120128686 - Austen; Matthias ; et al.	2012-05-24
Cycloalkyl Containing Thienopyrimidines For Pharmaceutical Compositions App 20110217311 - LEHMANN-LINTZ; Thorsten ; et al.	2011-09-08
Thienopyrimidines Containing A Substituted Alkyl Group For Pharmaceutical Compositions App 20110212103 - HECKEL; Armin ; et al.	2011-09-01
Heterocycloalkyl-containing Thienopyrimidines For Pharmaceutical Compositions App 20110212102 - LEHMANN-LINTZ; Thorsten ; et al.	2011-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.